Recombinant Photorhabdus luminescens subsp. laumondii Tyrosine--tRNA ligase 2 (tyrS2)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
tyrS2; plu0201; Tyrosine--tRNA ligase 2; EC 6.1.1.1; Tyrosyl-tRNA synthetase 2; TyrRS 2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-399
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Photorhabdus luminescens subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01)
Target Names
tyrS2
Target Protein Sequence
MKENIDKLLS NIAIMEPPLG LQDKLALARQ ENRKLTIKLG FDPTAPDLHL GHAVVLQKLK DFQDEGHRIV VIIGDFTAGI GDPTGRNKLR PPLTPEQINK NSQTYINQLA KVINIENIEI RKNSEWFNNM PFSNVIKLIS KITLAQIMHR DDFKTRFESK APVHLHEIIY PILQGYDSVM IDADIELGGT DQLFNNLVGR TLQEAYEKKG QIVITMPLLE GLDGIEKMSK SKNNYIGLTD NANDMYGKVM SIPDSVIINY LTLATDMEAE KQSAIVSQLE LGLNPMKIKK DIAYNIVKRY HDDISAKEAT EHFERVVQKR TPEEADHDVL ILPKGSYITL LDLCSVALPA ISRSELRRLI RSGAVRVDKS KEDDEIKNIE VIPGTLIWIG KRYKFRIGS
Uniprot No.

Target Background

Function

Function: Catalyzes the two-step attachment of tyrosine to tRNA(Tyr): tyrosine is first activated by ATP to form Tyr-AMP, which is then transferred to the acceptor end of tRNA(Tyr).

Database Links

KEGG: plu:plu0201

STRING: 243265.plu0201

Protein Families
Class-I aminoacyl-tRNA synthetase family, TyrS type 2 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Tyrosine--tRNA ligase 2 (tyrS2) from Photorhabdus luminescens and what is its functional significance?

Tyrosine--tRNA ligase 2 (tyrS2) from Photorhabdus luminescens subsp. laumondii is an aminoacyl-tRNA synthetase responsible for catalyzing the attachment of tyrosine to its cognate tRNA molecules during protein synthesis. The enzyme (EC 6.1.1.1) is also known as Tyrosyl-tRNA synthetase 2 (TyrRS 2) .

The functional significance of tyrS2 includes:

  • Essential role in translation accuracy by ensuring correct amino acid incorporation

  • Potential involvement in P. luminescens' dual lifestyle as both insect pathogen and nematode symbiont

  • Possible regulatory role in metabolic switching during lifecycle transitions

The protein consists of 399 amino acids with a sequence beginning with MKENIDKLLS and contains characteristic domains for ATP binding, tyrosine recognition, and tRNA interaction . Unlike many organisms that possess a single TyrRS, P. luminescens has a second TyrRS (tyrS2), suggesting potential specialized functions related to its complex lifestyle transitions.

How do researchers express and purify recombinant P. luminescens tyrS2 for experimental studies?

Expression and purification of recombinant P. luminescens tyrS2 typically follows this methodological workflow:

Expression System Selection:

  • Yeast expression systems have been successfully employed

  • E. coli systems (similar to those used for other P. luminescens proteins) can also be utilized with appropriate optimization

Purification Protocol:

  • Harvest cells and lyse using appropriate buffer systems

  • Employ affinity chromatography (typically His-tag based systems)

  • Follow with size exclusion chromatography for higher purity

  • Verify purity by SDS-PAGE (>85% purity is standard for commercial preparations)

Storage Recommendations:

  • For liquid preparations: 6 months at -20°C/-80°C

  • For lyophilized preparations: 12 months at -20°C/-80°C

  • Addition of 5-50% glycerol (final concentration) is recommended for long-term storage

  • Avoid repeated freeze-thaw cycles; store working aliquots at 4°C for up to one week

Researchers should reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL for optimal stability and activity.

What methodologies are most effective for assessing the enzymatic activity of recombinant P. luminescens tyrS2?

Several complementary approaches can be employed to assess the enzymatic activity of recombinant P. luminescens tyrS2:

ATP-PPi Exchange Assay:

  • Measures the first step of aminoacylation (amino acid activation)

  • Advantages: High sensitivity, does not require tRNA

  • Protocol: Incubate enzyme with tyrosine, ATP, and [32P]PPi, then measure [32P]ATP formation

Aminoacylation Assay:

  • Measures complete charging of tRNA with tyrosine

  • Protocol options:

    • Filter-binding assay with [14C]tyrosine

    • Acid gel electrophoresis to separate charged from uncharged tRNA

    • Thin layer chromatography following nuclease digestion

Steady-State Kinetic Analysis:

  • Determines key parameters (kcat, KM) for both amino acid and tRNA substrates

  • Experimental design should include varied substrate concentrations and optimized reaction conditions (pH 7.5-8.0, 2-5 mM MgCl2)

Fluorescence-Based Real-Time Assays:

  • Uses fluorescently labeled tRNA to monitor charging in real-time

  • Advantages: Continuous monitoring, reduced radioactive waste

For optimal activity assessment, researchers should control for potential inhibitors, ensure enzyme stability, and validate results using both positive controls (e.g., E. coli TyrRS) and negative controls (heat-inactivated enzyme).

How does P. luminescens tyrS2 compare to tyrosyl-tRNA synthetases from other organisms?

Comparative analysis reveals several notable differences between P. luminescens tyrS2 and other tyrosyl-tRNA synthetases:

Sequence Homology Comparison:
While no direct comparison data is available for P. luminescens tyrS2, analysis of related TyrRS proteins shows:

  • Bacterial TyrRS proteins typically share 30-50% sequence identity across species

  • Key active site residues for tyrosine binding are generally conserved

  • Anticodon recognition elements show greater variability

Structural Comparison with M. jannaschii TyrRS:
The well-characterized M. jannaschii TyrRS shows distinct structural features that may provide insights into P. luminescens tyrS2:

  • The anticodon recognition loop (residues 257-263) undergoes significant conformational changes upon tRNA binding

  • Loop 133-143 near the tRNA acceptor stem binding site becomes stabilized through tRNA interactions

  • Subtle cooperative movements occur in the tyrosine-binding pocket upon substrate binding

Functional Specialization:
Unlike many organisms with a single TyrRS, P. luminescens possesses tyrS2 as a second tyrosyl-tRNA synthetase, suggesting potential specialized functions that may correlate with its dual lifestyle as both insect pathogen and nematode symbiont . This specialization could be connected to the metabolic switch that regulates P. luminescens' transition between pathogenicity and mutualism .

What role might P. luminescens tyrS2 play in the organism's dual lifestyle as both insect pathogen and nematode symbiont?

P. luminescens exhibits a remarkable dual lifestyle, functioning as both an insect pathogen and nematode symbiont. While direct evidence for tyrS2's role in this lifestyle switch is limited, several hypotheses warrant investigation:

Metabolic Switch Regulation:
P. luminescens undergoes a metabolic switch during the transition from pathogenicity to mutualism, with the TCA cycle playing a critical role . As a key component of protein synthesis, tyrS2 could be differentially regulated during this transition to support altered protein expression profiles.

Research approach:

  • Compare tyrS2 expression levels between primary (1°) and secondary (2°) phenotypic variants

  • Investigate tyrS2 knockout effects on both pathogenicity and symbiosis capability

  • Analyze tyrS2 expression in response to nematode-derived signals

Secondary Metabolism Involvement:
P. luminescens produces numerous secondary metabolites during post-exponential growth, including antibiotics, pigments, and bioluminescence compounds . These metabolites require specialized enzymes whose synthesis might depend on optimized tyrS2 activity.

Research suggests that "secondary metabolism in P. luminescens is required for the mutualistic interaction with the nematode" but is "unaffected in virulence" , indicating a potential connection between translation regulation and lifestyle switching.

Connection to Environmental Adaptation:
The secondary (2°) cells of P. luminescens show increased environmental adaptation, including specific interactions with plant roots and fungal hyphae . TyrS2 might support the translation of proteins needed for these specialized interactions.

What approaches can researchers use to investigate potential moonlighting functions of P. luminescens tyrS2 beyond aminoacylation?

Aminoacyl-tRNA synthetases frequently possess secondary "moonlighting" functions beyond their primary role in translation. To investigate such possibilities for P. luminescens tyrS2:

Protein-Protein Interaction Studies:

  • Bacterial two-hybrid screening to identify interaction partners

  • Co-immunoprecipitation followed by mass spectrometry

  • Proximity-dependent biotin labeling (BioID) to capture transient interactions

Substrate Specificity Analysis:

  • Test non-canonical amino acid activation using ATP-PPi exchange assays

  • Investigate potential aminoacylation of specialized RNAs beyond canonical tRNATyr

  • Examine potential involvement in amino acid biosynthesis pathways

Conditional Gene Expression:

  • Create conditional tyrS2 mutants using inducible expression systems

  • Analyze phenotypic changes under various environmental conditions

  • Monitor impacts on secondary metabolism production

Cellular Localization Studies:

  • Generate fluorescent protein fusions to track subcellular localization

  • Perform fractionation studies to identify membrane or extracellular associations

  • Investigate potential secretion under specific environmental conditions

Researchers should focus particularly on conditions mimicking the transition between pathogenic and symbiotic lifestyles, as this represents a unique aspect of P. luminescens biology where specialized functions might be revealed.

How can site-directed mutagenesis of P. luminescens tyrS2 be optimized to investigate structure-function relationships?

Site-directed mutagenesis of P. luminescens tyrS2 can provide valuable insights into structure-function relationships. Based on approaches used for related TyrRS enzymes:

Target Selection Strategy:

  • Active site residues predicted to interact with tyrosine

  • Conserved motifs (e.g., KMSKS-like motifs) involved in ATP binding

  • Residues in the presumed anticodon recognition domain

  • Species-specific residues that differ from other bacterial TyrRS enzymes

Methodological Considerations:

  • PCR-based site-directed mutagenesis using overlapping primers

  • Gibson Assembly for multiple simultaneous mutations

  • Golden Gate Assembly for systematic residue scanning

Validation Protocol:

  • Sequence verification of mutations

  • Expression and purification under identical conditions

  • Circular dichroism to confirm proper folding

  • Size exclusion chromatography to verify oligomeric state

Functional Analysis Pipeline:

  • ATP-PPi exchange assay to evaluate amino acid activation

  • Aminoacylation assays with cognate tRNA

  • Binding studies using isothermal titration calorimetry

  • Thermal stability assessment via differential scanning fluorimetry

Drawing from the M. jannaschii TyrRS mutant studies, researchers should pay particular attention to:

  • Hydrogen bonding networks in the amino acid binding pocket

  • Conformational changes in key loops upon substrate binding

  • Potential cooperative movements among active site residues

What are the optimal crystallization conditions and approaches for structural determination of P. luminescens tyrS2?

Based on successful crystallization of related TyrRS enzymes, including M. jannaschii TyrRS , the following approaches are recommended:

Initial Screening Strategy:

  • Commercial sparse matrix screens (Hampton Research, Molecular Dimensions)

  • Systematic grid screens varying:

    • pH (6.5-8.5)

    • Precipitants (PEG 3350-8000, ammonium sulfate)

    • Salt concentrations (50-500 mM)

Protein Preparation Considerations:

  • High purity (>95% by SDS-PAGE)

  • Multiple constructs with varied N/C-terminal boundaries

  • Test both apo-enzyme and complexes with substrates/analogues

  • Assess monodispersity by dynamic light scattering

Optimization Techniques:

  • Microseeding from initial crystals

  • Additive screening with nucleotides, divalent cations

  • Surface entropy reduction (SER) by mutating surface lysine/glutamate patches

  • Crystallization with cognate tRNATyr or fragments

Data Collection and Processing:
Compare parameters with successful M. jannaschii TyrRS crystallization:

ParameterWild-type M. jannaschii TyrRSPotential P. luminescens tyrS2
Space groupP212121To be determined
Resolution (Å)2.66Target: <3.0 Å
Unit cell dimensionsa=45.1, b=185.3, c=95.5 ÅTo be determined
Molecules per asymmetric unit2Likely 2
Completeness (%)99.5Target: >95%

Researchers should consider crystallizing both apo-enzyme and enzyme-ligand complexes to capture conformational changes similar to those observed in M. jannaschii TyrRS upon tRNA binding .

How can researchers effectively investigate the potential role of P. luminescens tyrS2 in antibiotic resistance and virulence?

P. luminescens produces numerous antibiotics and virulence factors as part of its insect pathogenicity. The potential involvement of tyrS2 in these processes can be investigated through:

Gene Knockout/Knockdown Studies:

  • CRISPR-Cas9 gene editing for complete tyrS2 deletion

  • Antisense RNA approaches for partial knockdown

  • Analysis of effects on:

    • Antibiotic production (particularly 3-5-dihydroxy-4-isopropylstilbene)

    • Anthraquinone pigment synthesis

    • Bioluminescence production

Expression Analysis During Infection:

  • qRT-PCR to measure tyrS2 expression changes during:

    • Insect infection progression

    • Nematode colonization

    • Exposure to competitive microorganisms

  • RNA-seq for genome-wide expression correlation

Comparative Analysis with rpoB Mutants:
P. luminescens rifampin-resistant (RifR) mutants with rpoB mutations show altered nematicidal activity . Similar approaches could reveal tyrS2 involvement in:

  • Symbiosis establishment with nematodes

  • Insect virulence pathways

  • Secondary metabolite production

Heterologous Expression Studies:

  • Express P. luminescens tyrS2 in related Enterobacteriaceae

  • Assess impact on antibiotic sensitivity profiles

  • Investigate changes in virulence-associated phenotypes

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.